Related Experiment Video

Updated: Jun 22, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

A functional connection between pRB and transforming growth factor beta in growth inhibition and mammary gland

Sarah M Francis1, Jacqueline Bergsied, Christian E Isaac

  • 1London Regional Cancer Program, University of Western Ontario, London, Ontario N6A4L6, Canada.

Molecular and Cellular Biology
|June 10, 2009
PubMed

Insights

Retinoblastoma protein (pRB) is essential for normal mammary gland development and function. Loss of pRB function leads to breast cancer by disrupting transforming growth factor beta (TGF-beta) signaling pathways.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Developmental Biology

Background:

  • Transforming growth factor beta (TGF-beta) is vital for breast development and its loss is linked to breast cancer.
  • TGF-beta inhibits cyclin-dependent kinase (CDK) activity, causing pRB accumulation, but pRB's role in mammary development was unclear.

Purpose of the Study:

  • To investigate the role of retinoblastoma protein (pRB) in mammary gland development.
  • To elucidate the mechanism by which pRB functions within TGF-beta cytostatic signaling.

Main Methods:

  • Utilized gene-targeted mice with specific missense mutations in pRB (Rb1(DeltaL) and Rb1(NF)).
  • Analyzed mammary gland development, epithelial hyperplasia, and nursing defects in mutant mice.
  • Investigated the transcriptional repression of E2F target genes downstream of CDK activity.

Main Results:

  • Rb1 mutant mice exhibited hyperplastic mammary epithelium and nursing defects.
  • Mutant mice showed insensitivity to TGF-beta-induced growth inhibition.
  • Demonstrated that pRB-mediated transcriptional repression of E2F targets is crucial for TGF-beta cytostatic signaling.

Conclusions:

  • pRB plays a critical, previously unrecognized role in mammary gland development.
  • Active transcriptional repression by pRB is a key component of TGF-beta's growth inhibitory function.
  • Established a novel link between pRB and TGF-beta in regulating cell growth and mammary development.

More Related Videos

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

Spheroid Assay to Measure TGF-β-induced Invasion09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...